Helperby is pioneering one of the most important developments in antibiotic discovery since Alexander Fleming’s original breakthrough in 1928. Helperby’s first antibiotic candidate that significantly induces reduced levels of bacterial resistance is already in Phase III human clinical trials.
This site explains who we are, what we do and how our work is helping combat antibiotic-resistant bacteria.
> What is Helperby doing to save antibiotics for future generations?
> Which antibiotics are in our pipeline?